XML 93 R79.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION - Summary Of Stock Options Activity (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Number of Options    
Options, outstanding at beginning of period (in shares) 1,300,000 0
Granted (in shares) 774,505 1,300,000
Options, outstanding at end of period (in shares) 2,074,505 1,300,000
Options vested at December 31, 2022 (in shares) 442,000  
Options exercisable at December 31, 2022 (in shares) 442,000  
Weighted Average Exercise Price per Share    
Beginning balance, weighted average exercise price per share (in USD per share) $ 8.51 $ 10.00
Granted (in USD per share) 6.00 10.00
Ending balance, weighted average exercise price per share (in USD per share) 8.51 10.00
Options vested at December 31, 2022 (in USD per share) 10.00  
Options exercisable at December 31, 2022 (in USD per share) 10.00  
Weighted Average Grant Date Value per Option    
Beginning balance, weighted average grant date value per option (in USD per share) 2.21  
Weighted-average grant date fair value (in dollars per share) 1.95 2.21
Ending balance, weighted average grant date value per option (in USD per share) 2.11 $ 2.21
Options vested and exercisable at December 31, 2022 (in USD per share) $ 2.21  
Weighted Average Remaining Contractual Term    
Granted, term 9 years 1 month 6 days 9 years 8 months 12 days
Options outstanding, Weighted average remaining contractual term 8 years 10 months 24 days 9 years 8 months 12 days
Options vested and exercisable at December 31, 2022, term 8 years 8 months 12 days